tibolone

Trade name: xyvion

Small moleculeexperimental

Clinical trial activity

21 trials · 18 clinical orgs · 0 marketing orgs

Phase 1
2
Phase 2
7
Phase 3
6
Phase 4
10

Earliest trial started Oct 1, 2000 (NCT00431431)

Timeline

2000s

  1. Jan 1, 2001

    Earliest Phase 3 Sponsor(trial)

  2. Jan 1, 2004

    Earliest Phase 2 Sponsor(trial)

2010s

  1. Jan 1, 2012

    Earliest Phase 1 Sponsor(trial)

Indications

Approved for

Mechanism of action

Chemistry & pharmacology

Loading structure…

SMILES

C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C
Mol. weight
312.45 g/mol
Lipinski Ro5
Pass
Rule of 3
No
Chirality
Single Stereoisomer
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • 17-hydroxy-7alpha-methyl-19-nor-17alpha-pregn-5(10)-en-20-yn-3-one
  • 17-hydroxy-7alpha-methyl-19-nor-17alpha-pregn-5(10)-en-20-yn-3-one
  • 19-norpregn-5(10)-en-20-yn-3-one, 17-hydroxy-7-methyl-, (7-alpha,17-alpha)-
  • berenguer infale brand of tibolone
  • boltin
  • livial
  • livial
  • livial
  • liviella
  • liviella
  • organon brand of tibolone
  • org od14
  • org od 14
  • org od 14
  • org od 14
  • tibilone
  • tibolona
  • tibolona
  • tibolone
  • tibolone
  • tibolone
  • tibolone
  • tibolone
  • tibolone
  • tibolone
  • tibolone
  • tibolonum
  • tibolonum
  • xyvion

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT02393482Phase 4Jun 1, 2016University of Cagliari
NCT01764178Phase 1Jan 22, 2013JW Pharmaceutical, University of Ulsan
NCT01822288Phase 4Dec 1, 2012Far Eastern Memorial Hospital
NCT01368068Phase 4Jul 1, 2012Monash University, The Alfred Hospital
NCT01470092Phase 4Jul 1, 2012Monash University, The Alfred Hospital
NCT01543399N/AMar 1, 2012Federal University of Minas Gerais
NCT01679795N/AFeb 1, 2012Federal University of Minas Gerais
NCT01239888Phase 1Jan 1, 2012Monash University, The Alfred Hospital
NCT00472004Phase 4Feb 1, 2006Pfizer
NCT00145522Phase 4Nov 1, 2005Solvay
NCT00809068Phase 4Aug 1, 2005Keogh Institute for Medical Research, University of Western Australia
NCT00299364Phase 3Sep 1, 2004Peking University, Schaper & Bruemmer GmbH & Co KG
NCT00165204Phase 2Apr 1, 2004Department of Defense, Harvard University
NCT00413764Phase 3Mar 23, 2004Merck
NCT00294463Phase 4Feb 1, 2003Erasmus University Rotterdam, Organon
NCT00725374Phase 3Dec 15, 2002Merck
NCT00431093Phase 4Nov 1, 2002Merck
NCT00408863Phase 3May 1, 2002Merck
NCT00745108Phase 3Oct 1, 2001Merck
NCT00519857Phase 3Jul 1, 2001Merck
Showing 20 of 21 trials
Page 1 / 2

Organizations

Research & Development (18)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
MerckFor profit7722000
Monash UniversityAcademic/Hospital3322012
The Alfred HospitalAcademic/Hospital3022012
Federal University of Minas GeraisAcademic/Hospital2212012
Department of DefenseGovernment1012004
Erasmus University RotterdamAcademic/Hospital1112003
Far Eastern Memorial HospitalAcademic/Hospital1112012
Harvard UniversityAcademic/Hospital1112004
JW PharmaceuticalFor profit1112013
Keogh Institute for Medical ResearchAcademic/Hospital1112005
OrganonFor profit1012003
Peking UniversityAcademic/Hospital1012004
PfizerFor profit1112006
Schaper & Bruemmer GmbH & Co KGFor profit1112004
SolvayFor profit1112005
University of CagliariAcademic/Hospital1112016
University of UlsanAcademic/Hospital1012013
University of Western AustraliaAcademic/Hospital1012005
18 organizations
Page 1 / 1